BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 11782716)

  • 1. [The activation of the phosphotyrosine phosphatase eta is responsible for the somatostatin inhibition of PCCl3 thyroid cell proliferation].
    Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Villa V; Pattarozzi A; Diana F; Fusco A; Schettini G
    Minerva Endocrinol; 2001 Dec; 26(4):277-83. PubMed ID: 11782716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation.
    Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Pattarozzi A; Bajetto A; Trapasso F; Fusco A; Schettini G
    Mol Endocrinol; 2001 Oct; 15(10):1838-52. PubMed ID: 11579215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phosphotyrosine phosphatase eta mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2.
    Massa A; Barbieri F; Aiello C; Iuliano R; Arena S; Pattarozzi A; Corsaro A; Villa V; Fusco A; Zona G; Spaziante R; Schettini G; Florio T
    Ann N Y Acad Sci; 2004 Dec; 1030():264-74. PubMed ID: 15659806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogene transformation of PC Cl3 clonal thyroid cell line induces an autonomous pattern of proliferation that correlates with a loss of basal and stimulated phosphotyrosine phosphatase activity.
    Florio T; Scorziello A; Thellung S; Salzano S; Berlingieri MT; Fusco A; Schettini G
    Endocrinology; 1997 Sep; 138(9):3756-63. PubMed ID: 9275062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of the phosphotyrosine phosphatase DEP-1/PTPeta dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferation.
    Massa A; Barbieri F; Aiello C; Arena S; Pattarozzi A; Pirani P; Corsaro A; Iuliano R; Fusco A; Zona G; Spaziante R; Florio T; Schettini G
    J Biol Chem; 2004 Jul; 279(28):29004-12. PubMed ID: 15123617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein tyrosine phosphatase-eta expression is upregulated by the PKA-dependent and is downregulated by the PKC-dependent pathways in thyroid cells.
    Martelli ML; Trapasso F; Bruni P; Berlingieri MT; Battaglia C; Vento MT; Belletti B; Iuliano R; Santoro M; Viglietto G; Fusco A
    Exp Cell Res; 1998 Nov; 245(1):195-202. PubMed ID: 9828116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin/somatostatin receptor signalling: phosphotyrosine phosphatases.
    Florio T
    Mol Cell Endocrinol; 2008 May; 286(1-2):40-8. PubMed ID: 17913342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo.
    Iuliano R; Trapasso F; Le Pera I; Schepis F; Samà I; Clodomiro A; Dumon KR; Santoro M; Chiariotti L; Viglietto G; Fusco A
    Cancer Res; 2003 Feb; 63(4):882-6. PubMed ID: 12591742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue.
    Pera IL; Iuliano R; Florio T; Susini C; Trapasso F; Santoro M; Chiariotti L; Schettini G; Viglietto G; Fusco A
    Oncogene; 2005 Apr; 24(19):3187-95. PubMed ID: 15735685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An intracellular multi-effector complex mediates somatostatin receptor 1 activation of phospho-tyrosine phosphatase eta.
    Arena S; Pattarozzi A; Massa A; Esteve JP; Iuliano R; Fusco A; Susini C; Florio T
    Mol Endocrinol; 2007 Jan; 21(1):229-46. PubMed ID: 17021051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1).
    Trapasso F; Iuliano R; Boccia A; Stella A; Visconti R; Bruni P; Baldassarre G; Santoro M; Viglietto G; Fusco A
    Mol Cell Biol; 2000 Dec; 20(24):9236-46. PubMed ID: 11094075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin inhibits PC Cl3 thyroid cell proliferation through the modulation of phosphotyrosine activity. Impairment of the somatostatinergic effects by stable expression of E1A viral oncogene.
    Florio T; Scorizello A; Fattore M; D'Alto V; Salzano S; Rossi G; Berlingieri MT; Fusco A; Schettini G
    J Biol Chem; 1996 Mar; 271(11):6129-36. PubMed ID: 8626400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin enhances the chemosensitivity of GBC-SD cell line to doxorubicin through arresting the cell cycle to S phase rather than through the P53/Bax-depended apoptosis way in vitro.
    Songgang L; Jiyu L; Gongwei ; Yingbin L; Yiyu Q; Zhiwei Q
    Hepatogastroenterology; 2009; 56(94-95):1253-60. PubMed ID: 19950772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortistatin production by HepG2 human hepatocellular carcinoma cell line and distribution of somatostatin receptors.
    Notas G; Kolios G; Mastrodimou N; Kampa M; Vasilaki A; Xidakis C; Castanas E; Thermos K; Kouroumalis E
    J Hepatol; 2004 May; 40(5):792-8. PubMed ID: 15094227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of receptor-type protein tyrosine phosphatase eta function inhibits human pancreatic carcinoma cell growth in vitro and in vivo.
    Trapasso F; Yendamuri S; Dumon KR; Iuliano R; Cesari R; Feig B; Seto R; Infante L; Ishii H; Vecchione A; During MJ; Croce CM; Fusco A
    Carcinogenesis; 2004 Nov; 25(11):2107-14. PubMed ID: 15231692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro.
    de Bruin C; Feelders RA; Waaijers AM; van Koetsveld PM; Sprij-Mooij DM; Lamberts SW; Hofland LJ
    J Mol Endocrinol; 2009 Jan; 42(1):47-56. PubMed ID: 18852217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin modulates PI3K-Akt, eNOS and NHE activity in the ciliary epithelium.
    Ghosh S; Choritz L; Geibel J; Coca-Prados M
    Mol Cell Endocrinol; 2006 Jul; 253(1-2):63-75. PubMed ID: 16764985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
    Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
    J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling.
    Paling NR; Welham MJ
    Biochem J; 2002 Dec; 368(Pt 3):885-94. PubMed ID: 12220225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin receptors 1, 2, and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro via a phosphotyrosine phosphatase-eta-dependent inhibition of extracellularly regulated kinase-1/2.
    Barbieri F; Pattarozzi A; Gatti M; Porcile C; Bajetto A; Ferrari A; Culler MD; Florio T
    Endocrinology; 2008 Sep; 149(9):4736-46. PubMed ID: 18566118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.